Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cumberland Pharmaceuticals (CPIX) Current Leases (2019 - 2026)

Cumberland Pharmaceuticals' Current Leases history spans 7 years, with the latest figure at $467774.0 for Q4 2025.

  • On a quarterly basis, Current Leases rose 31.21% to $467774.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $467774.0, a 31.21% increase, with the full-year FY2025 number at $467774.0, up 31.21% from a year prior.
  • Current Leases hit $467774.0 in Q4 2025 for Cumberland Pharmaceuticals, up from $401445.0 in the prior quarter.
  • Over the last five years, Current Leases for CPIX hit a ceiling of $1.1 million in Q3 2021 and a floor of $158369.0 in Q1 2023.
  • Historically, Current Leases has averaged $506517.0 across 5 years, with a median of $381428.5 in 2024.
  • Biggest five-year swings in Current Leases: crashed 82.17% in 2022 and later skyrocketed 128.73% in 2024.
  • Tracing CPIX's Current Leases over 5 years: stood at $969677.0 in 2021, then crashed by 82.17% to $172910.0 in 2022, then skyrocketed by 101.31% to $348092.0 in 2023, then rose by 2.42% to $356508.0 in 2024, then soared by 31.21% to $467774.0 in 2025.
  • Business Quant data shows Current Leases for CPIX at $467774.0 in Q4 2025, $401445.0 in Q3 2025, and $386077.0 in Q2 2025.